Sitagliptin And Metformin Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 10370-351

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 10370-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure1 (Sitagliptin And Metformin 1)

Chemical structure of sitagliptin phosphate illustrating its molecular arrangement including trifluoromethyl and fluorophenyl groups. The diagram includes the phosphate group represented as H3PO4 indicating the salt form.*

FDA Label Image

Structure2 (Sitagliptin And Metformin 2)

Chemical structure diagram of sitagliptin hydrochloride, showing its molecular components and arrangement including methyl groups, nitrogen atoms, and amine groups with an HCl moiety.*

FDA Label Image

Figure1 (Sitagliptin And Metformin 3)

A line graph showing LS mean change from baseline over 24 weeks. The x-axis represents time in weeks (0 to 24), and the y-axis shows LS mean change from baseline ranging from approximately -0.1 to -2.1. Multiple lines indicate different data groups, each showing trends across the weeks.*

FDA Label Image

Figure2 (Sitagliptin And Metformin 4)

A line graph comparing the least squares mean change from baseline over 52 weeks for Sitagliptin 100 mg and Glipizide. The x-axis represents time in weeks, and the y-axis shows the LS mean change from baseline. Two lines, one with diamonds and one with circles, depict the changes for each drug across the study duration.*

FDA Label Image

50 mg/ 500 mg Label (Sitagliptin And Metformin 5)

Label for Sitagliptin and Metformin Hydrochloride Extended-Release Tablets, 50 mg/500 mg, film-coated tablets. The package contains 60 tablets and is labeled by Par Health USA, LLC. The label includes dosage instructions, storage information, and a depiction of an oval blue tablet imprinted with A317.*

FDA Label Image

50 mg/ 1000 mg Label (Sitagliptin And Metformin 6)

Label for Sitagliptin and Metformin Hydrochloride Extended-Release Tablets, 50 mg/1,000 mg strength. The label shows it is a prescription drug with 60 film-coated extended-release tablets per container, manufactured by Par Health USA, LLC. The green tablet on the label is imprinted with A318.*

FDA Label Image

100 mg/ 1000 mg Label (Sitagliptin And Metformin 7)

Sitagliptin and Metformin Hydrochloride Extended-Release Tablets 100 mg/1,000 mg film-coated tablets, packaged as 30 tablets per bottle. The label includes directions for use, storage instructions, and a blue oblong tablet imprinted with "A351". Manufactured by Par Health USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.